◆ TICKERBASEOpen interactive view →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocksM › MOLBIO

Molbio Diagnostics Limited (MOLBIO) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Medical Devices · DATA UPDATED 2026-09-20

Molbio Diagnostics Limited (MOLBIO) operates in the Medical Devices industry and is headquartered in Verna, India with about 1,225 employees. Its market capitalization is roughly ₹148 billion. In the fiscal year ended 2026-03-31, MOLBIO reported ₹14.1B in revenue and ₹1.7B in net income.

Molbio Diagnostics Limited, a point-of-care diagnostics company, provides healthcare technologies to diagnose infectious and non-communicable diseases. It manufactures and sells chip based diagnostic devices, chips and reagents, X-ray equipment's, and single/dual detectors.

Interactive charts & full statements →

MOLBIO Revenue & Earnings History — Annual Income Statement

Income statement2026-03-312025-03-312024-03-312023-03-31
Total Revenue₹14.1B₹10.0B₹8.2B₹3.2B
Gross Profit₹8.3B₹5.8B₹4.8B₹1.8B
Operating Income (EBIT)₹2.8B₹2.3B₹2.1B₹136M
Net Income₹1.7B₹1.5B₹1.0B(₹7M)

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

MOLBIO Free Cash Flow History

MOLBIO Balance Sheet History

Balance sheet2026-03-312025-03-312024-03-312023-03-31
Total Assets₹21.5B₹14.6B₹12.2B₹10.3B
Total Liabilities₹8.4B₹4.9B₹3.9B₹3.0B

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive MOLBIO viewer.

Other Companies in Medical Devices

← MOLAll “M” companiesMOLDTECH →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.